Hepatitis C virus constructs characterized by high efficiency replication
US6930095B2 · kind B2 · utility
4Cited by
6References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 7, 2001 |
| Grant date | Aug 16, 2005 |
| Priority date | — |
| Expiry date | Nov 7, 2021 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2469/20
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to recombinant hepatitis C virus (HCV)-derived nucleic acids and to stable rapidly growing cell clones derived from human hepatoma Huh-7 cell line and supporting high titer replication of said recombinant HCV nucleic acids. The subgenomic HCV replicons and cell clones of the instant invention represent the in vitro system of choice for studies of HCV propagation, anti-viral drug screening, and vaccine development.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.